Combined Efficacy of Biologically Synthesized Silver Nanoparticles and Different Antibiotics Against Multidrug-resistant Bacteria

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2013 Aug 30

PMID 23986635

Citations 82

Authors

Syed Zeeshan Haider Naqvi

Urooj Kiran

Muhammad Ishtiaq Ali

Asif Jamal

Abdul Hameed

Safia Ahmed

Naeem Ali

Affiliations

Soon will be listed here.

Abstract

Biological synthesis of nanoparticles is a growing innovative approach that is relatively cheaper and more environmentally friendly than current physicochemical processes. Among various microorganisms, fungi have been found to be comparatively more efficient in the synthesis of nanomaterials. In this research work, extracellular mycosynthesis of silver nanoparticles (AgNPs) was probed by reacting the precursor salt of silver nitrate (AgNO3) with culture filtrate of Aspergillus flavus. Initially, the mycosynthesis was regularly monitored by ultraviolet-visible spectroscopy, which showed AgNP peaks of around 400-470 nm. X-ray diffraction spectra revealed peaks of different intensities with respect to angle of diffractions (2θ) corresponding to varying configurations of AgNPs. Transmission electron micrographs further confirmed the formation of AgNPs in size ranging from 5-30 nm. Combined and individual antibacterial activities of the five conventional antibiotics and AgNPs were investigated against eight different multidrug-resistant bacterial species using the Kirby-Bauer disk-diffusion method. The decreasing order of antibacterial activity (zone of inhibition in mm) of antibiotics, AgNPs, and their conjugates against bacterial group (average) was; ciprofloxacin + AgNPs (23) . imipenem + AgNPs (21) > gentamycin + AgNPs (19) > vancomycin + AgNPs (16) > AgNPs (15) . imipenem (14) > trimethoprim + AgNPs (14) > ciprofloxacin (13) > gentamycin (11) > vancomycin (4) > trimethoprim (0). Overall, the synergistic effect of antibiotics and nanoparticles resulted in a 0.2-7.0 (average, 2.8) fold-area increase in antibacterial activity, which clearly revealed that nanoparticles can be effectively used in combination with antibiotics in order to improve their efficacy against various pathogenic microbes.

Citing Articles

Ag-AgO nanocomposite biosynthesis by mixed bacterial cultivation and effect of the ph on size and optical properties of the nanocomposite.

Al-Asbahi M, Al-Ofiri B, Saad F, Alnehia A, Hadi M J Mater Sci Mater Med. 2025; 36(1):19.

PMID: 39907862 PMC: 11799101. DOI: 10.1007/s10856-024-06851-6.

Bioactive potency of extracts from and with silver nanoparticles against cancer cell lines and pathogenic bacteria.

Alqaraleh M, Khleifat K, Al-Samydai A, Al-Najjar B, Saqallah F, Al Qaisi Y Biomed Rep. 2025; 22(2):34.

PMID: 39777210 PMC: 11704841. DOI: 10.3892/br.2024.1912.

Enhanced Efficacy of Some Antibiotics in the Presence of Silver Nanoparticles Against Clinical Isolate of Recovered from Cystic Fibrosis Patients.

Al-Momani H, Albalawi H, Al Balawi D, Khleifat K, Aolymat I, Hamed S Int J Nanomedicine. 2024; 19:12461-12481.

PMID: 39611007 PMC: 11602434. DOI: 10.2147/IJN.S479937.

Silver Nanoparticles: A Comprehensive Review of Synthesis Methods and Chemical and Physical Properties.

Duman H, Eker F, Akdasci E, Witkowska A, Bechelany M, Karav S Nanomaterials (Basel). 2024; 14(18).

PMID: 39330683 PMC: 11434896. DOI: 10.3390/nano14181527.

Recent Advances in the Development of Metal/Metal Oxide Nanoparticle and Antibiotic Conjugates (MNP-Antibiotics) to Address Antibiotic Resistance: Review and Perspective.

Abdullah , Jamil T, Atif M, Khalid S, Metwally K, Yahya G Int J Mol Sci. 2024; 25(16).

PMID: 39201601 PMC: 11354832. DOI: 10.3390/ijms25168915.

References

Yamanaka M, Hara K, Kudo J . Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol. 2005; 71(11):7589-93. PMC: 1287701. DOI: 10.1128/AEM.71.11.7589-7593.2005. View

Kim J, Kuk E, Yu K, Kim J, Park S, Lee H . Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007; 3(1):95-101. DOI: 10.1016/j.nano.2006.12.001. View

Dahl J, Maddux B, Hutchison J . Toward greener nanosynthesis. Chem Rev. 2007; 107(6):2228-69. DOI: 10.1021/cr050943k. View

Kalimuthu K, Suresh Babu R, Venkataraman D, Bilal M, Gurunathan S . Biosynthesis of silver nanocrystals by Bacillus licheniformis. Colloids Surf B Biointerfaces. 2008; 65(1):150-3. DOI: 10.1016/j.colsurfb.2008.02.018. View

Birla S, Tiwari V, Gade A, Ingle A, Yadav A, Rai M . Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Lett Appl Microbiol. 2009; 48(2):173-9. DOI: 10.1111/j.1472-765X.2008.02510.x. View

Pissuwan D, Niidome T, Cortie M . The forthcoming applications of gold nanoparticles in drug and gene delivery systems. J Control Release. 2009; 149(1):65-71. DOI: 10.1016/j.jconrel.2009.12.006. View

Kim K, Sung W, Moon S, Choi J, Kim J, Lee D . Antifungal effect of silver nanoparticles on dermatophytes. J Microbiol Biotechnol. 2008; 18(8):1482-4. View

Rai M, Deshmukh S, Ingle A, Gade A . Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J Appl Microbiol. 2012; 112(5):841-52. DOI: 10.1111/j.1365-2672.2012.05253.x. View

Bhainsa K, DSouza S . Extracellular biosynthesis of silver nanoparticles using the fungus Aspergillus fumigatus. Colloids Surf B Biointerfaces. 2006; 47(2):160-4. DOI: 10.1016/j.colsurfb.2005.11.026. View

10.

Klueh U, WAGNER V, Kelly S, Johnson A, Bryers J . Efficacy of silver-coated fabric to prevent bacterial colonization and subsequent device-based biofilm formation. J Biomed Mater Res. 2000; 53(6):621-31. DOI: 10.1002/1097-4636(2000)53:6<621::aid-jbm2>3.0.co;2-q. View

11.

Kollef M, Golan Y, Micek S, Shorr A, Restrepo M . Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit. Clin Infect Dis. 2011; 53 Suppl 2:S33-55. PMC: 3161517. DOI: 10.1093/cid/cir475. View

12.

Sondi I, Salopek-Sondi B . Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004; 275(1):177-82. DOI: 10.1016/j.jcis.2004.02.012. View

13.

Zhang X, Yan S, Tyagi R, Surampalli R . Synthesis of nanoparticles by microorganisms and their application in enhancing microbiological reaction rates. Chemosphere. 2010; 82(4):489-94. DOI: 10.1016/j.chemosphere.2010.10.023. View

14.

Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet J . Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemother. 2008; 61(4):869-76. DOI: 10.1093/jac/dkn034. View

15.

Nanda A, Saravanan M . Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE. Nanomedicine. 2009; 5(4):452-6. DOI: 10.1016/j.nano.2009.01.012. View

16.

Allahverdiyev A, Kon K, Abamor E, Bagirova M, Rafailovich M . Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti Infect Ther. 2011; 9(11):1035-52. DOI: 10.1586/eri.11.121. View

17.

Fayaz A, Balaji K, Girilal M, Yadav R, Kalaichelvan P, Venketesan R . Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomedicine. 2009; 6(1):103-9. DOI: 10.1016/j.nano.2009.04.006. View

18.

Jain N, Bhargava A, Majumdar S, Tarafdar J, Panwar J . Extracellular biosynthesis and characterization of silver nanoparticles using Aspergillus flavus NJP08: a mechanism perspective. Nanoscale. 2010; 3(2):635-41. DOI: 10.1039/c0nr00656d. View

19.

Yoon K, Byeon J, Park J, Hwang J . Susceptibility constants of Escherichia coli and Bacillus subtilis to silver and copper nanoparticles. Sci Total Environ. 2006; 373(2-3):572-5. DOI: 10.1016/j.scitotenv.2006.11.007. View

20.

Vaidyanathan R, Kalishwaralal K, Gopalram S, Gurunathan S . Nanosilver--the burgeoning therapeutic molecule and its green synthesis. Biotechnol Adv. 2009; 27(6):924-937. DOI: 10.1016/j.biotechadv.2009.08.001. View